US Drug Recall Register
Class III · Low risk Terminated Initiated Nov 30, 2018 (8 years ago)

NYSTATIN Oral Suspension

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification for impurities.

What was recalled

NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose cups per tray, 5 trays per case) NDC 66689-037-50; b) 100 unit dose cups (10x5ml unit dose cups per tray, 10 trays per case) NDC 66689-037-99. Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771

Recalling firm
VistaPharm, Inc.
NDC code
66689-037-50
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0348-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Nystatin recalls

See all
Class II · Moderate risk Ongoing

Nystatin Cream USP

Reason Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

Padagis US LLC NDC 45802-059-35 D-0677-2026
Class II · Moderate risk Ongoing

Nystatin 150 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-1 D-0157-2024
Class II · Moderate risk Ongoing

Nystatin 2 Bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-4 D-0156-2024
Class II · Moderate risk Ongoing

Nystatin 500 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-3 D-0155-2024
Class II · Moderate risk Ongoing

Nystatin 5bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-5 D-0154-2024